Farnum Rhonda 4
4 · Theravance Biopharma, Inc. · Filed Jul 12, 2024
Insider Transaction Report
Form 4
Farnum Rhonda
SVP, COMM & MEDICAL AFFAIRS
Transactions
- Sale
Ordinary Shares
2024-07-10$9.00/sh−4,000$36,000→ 335,965 total
Footnotes (1)
- [F1]This transaction was executed in accordance with the reporting person's 10b5-1 plan dated 03/14/2024.